HPLC-MART
Sign in with Google
Product no. 108083-0005 Active
Get quote
Catalog Search results 108083-0005

108083-0005

Back to results All columns of this brand
108083-0005
Order / Price
Price on request

Sepax Bio 300 C8

by Sepax Technologies

Sepax Bio-C8 Capillary Columns                     

  • Most comprehensive selection of the stationary phases
  • Pioneered sub-2 µm PS/DVB based ion-exchange phases
  • Combined high efficiency and high capacity for non-porous Proteomix ion-exchange phases
  • High speed, high recovery and high stability
  • Column ID selection of 75, 150, and 300 µm and length selection of 5, 10 and 15 cm
Application areas:
Acidic compounds Basic compounds Neutral compounds Peptides Pharmaceutical molecules
Specification
Vendor Sepax Technologies Internal Diameter
Brand Sepax Bio 300 C8 Pore size 300
Modifification Silica/C8 Surface Area 105
Mode Reversed-Phase Carbon Load, % 4.0
Particle Size pH stability from 2.0
Length pH stability to 7.0
Similar columns Columns with same mode & modification — across all brands
VendorBrandModeModification Int. diam.LengthParticlesPoresPrice
Phenomenex Kinetex C8 Reversed-Phase Silica/C8 3.0 mm 100 mm 2.6 μm 100 Å On request
ACE ACE C8 Reversed-Phase Silica/C8 10.0 mm 75 mm 10.0 μm 100 Å On request
LabHut Cronusil-L C8 Reversed-Phase Silica/C8 4.6 mm 150 mm 3.0 μm 120 Å 262.55
CERI L-column2 C8 Reversed-Phase Silica/C8 1.5 mm 150 mm 5.0 μm 120 Å On request
TOSOH TSKgel Reversed-Phase Silica/C8 4.6 mm 150 mm 5.0 μm 100 Å On request
Vertical Chromatography VertiSep GES C8 Reversed-Phase Silica/C8 2.1 mm 100 mm 5.0 μm 120 Å On request
Vertical Chromatography VertiSep AQS C8 Reversed-Phase Silica/C8 2.1 mm 150 mm 5.0 μm 120 Å On request
SiliCYCLE SiliaChrom SB C8 Reversed-Phase Silica/C8 10.0 mm 250 mm 5.0 μm 150 Å On request
Customer feedback

No customer reviews yet. Be the first to share your experience!

Back to search results
Advertise With Us

Reach thousands of HPLC scientists and researchers. Fill in your details and our team will contact you shortly.